Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDIA GLYCOLS vs STERLING BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDIA GLYCOLS STERLING BIOTECH INDIA GLYCOLS/
STERLING BIOTECH
 
P/E (TTM) x 15.7 -0.0 - View Chart
P/BV x 1.3 0.1 1,711.2% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 INDIA GLYCOLS   STERLING BIOTECH
EQUITY SHARE DATA
    INDIA GLYCOLS
Mar-23
STERLING BIOTECH
Mar-18
INDIA GLYCOLS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,1537 17,032.5%   
Low Rs5652 34,454.3%   
Sales per share (Unadj.) Rs-432.812.7 -3,414.9%  
Earnings per share (Unadj.) Rs45.6-36.9 -123.3%  
Cash flow per share (Unadj.) Rs75.9-27.9 -272.0%  
Dividends per share (Unadj.) Rs7.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs614.210.1 6,059.5%  
Shares outstanding (eoy) m30.96272.17 11.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x-2.00.3 -598.3%   
Avg P/E ratio x18.9-0.1 -16,566.3%  
P/CF ratio (eoy) x11.3-0.2 -7,512.3%  
Price / Book Value ratio x1.40.4 337.2%  
Dividend payout %16.50-   
Avg Mkt Cap Rs m26,5981,144 2,324.1%   
No. of employees `000NANA-   
Total wages/salary Rs m888583 152.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m-13,3993,449 -388.5%  
Other income Rs m27255 494.9%   
Total revenues Rs m-13,1273,504 -374.6%   
Gross profit Rs m3,350-7,582 -44.2%  
Depreciation Rs m9402,457 38.2%   
Interest Rs m1,0334,397 23.5%   
Profit before tax Rs m1,650-14,381 -11.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m240-4,327 -5.5%   
Profit after tax Rs m1,410-10,054 -14.0%  
Gross profit margin %-25.0-219.8 11.4%  
Effective tax rate %14.530.1 48.3%   
Net profit margin %-10.5-291.5 3.6%  
BALANCE SHEET DATA
Current assets Rs m16,4624,807 342.5%   
Current liabilities Rs m18,64956,226 33.2%   
Net working cap to sales %16.3-1,490.7 -1.1%  
Current ratio x0.90.1 1,032.6%  
Inventory Days Days-1011,685 -6.0%  
Debtors Days Days-1,172543 -215.8%  
Net fixed assets Rs m32,11465,836 48.8%   
Share capital Rs m310272 113.8%   
"Free" reserves Rs m18,7052,486 752.3%   
Net worth Rs m19,0142,759 689.3%   
Long term debt Rs m5,50819,787 27.8%   
Total assets Rs m48,58370,643 68.8%  
Interest coverage x2.6-2.3 -114.4%   
Debt to equity ratio x0.37.2 4.0%  
Sales to assets ratio x-0.30 -564.8%   
Return on assets %5.0-8.0 -62.8%  
Return on equity %7.4-364.5 -2.0%  
Return on capital %10.9-44.3 -24.7%  
Exports to sales %-39.522.8 -173.6%   
Imports to sales %-32.50.6 -5,451.0%   
Exports (fob) Rs m5,295785 674.2%   
Imports (cif) Rs m4,35121 21,172.7%   
Fx inflow Rs m5,295785 674.2%   
Fx outflow Rs m14,87126 56,628.4%   
Net fx Rs m-9,575759 -1,261.3%   
CASH FLOW
From Operations Rs m3,257-328 -992.8%  
From Investments Rs m-3,303-91 3,610.4%  
From Financial Activity Rs m-5384 -1.3%  
Net Cashflow Rs m-51-35 144.2%  

Share Holding

Indian Promoters % 61.0 24.6 247.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.9 21.9 8.6%  
FIIs % 1.8 7.5 23.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.0 75.4 51.7%  
Shareholders   59,579 35,184 169.3%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDIA GLYCOLS With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    YASHO INDUSTRIES    NAVIN FLUORINE    


More on INDIA GLYCOLS vs Sterling Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

INDIA GLYCOLS vs Sterling Biotech Share Price Performance

Period INDIA GLYCOLS Sterling Biotech
1-Day 1.06% -4.94%
1-Month -3.97% 6.94%
1-Year 28.97% -78.61%
3-Year CAGR 17.27% -46.43%
5-Year CAGR 25.14% -32.29%

* Compound Annual Growth Rate

Here are more details on the INDIA GLYCOLS share price and the Sterling Biotech share price.

Moving on to shareholding structures...

The promoters of INDIA GLYCOLS hold a 61.0% stake in the company. In case of Sterling Biotech the stake stands at 24.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDIA GLYCOLS and the shareholding pattern of Sterling Biotech.

Finally, a word on dividends...

In the most recent financial year, INDIA GLYCOLS paid a dividend of Rs 7.5 per share. This amounted to a Dividend Payout ratio of 16.5%.

Sterling Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of INDIA GLYCOLS, and the dividend history of Sterling Biotech.



Today's Market

Sensex Tops 74,000 in Mock Trading Session Today | HAL, Mazagon Dock, Bharat Dynamics Surge 5% | All Sectoral Indices in Green Sensex Tops 74,000 in Mock Trading Session Today | HAL, Mazagon Dock, Bharat Dynamics Surge 5% | All Sectoral Indices in Green(Closing)

Indian share markets ended the mock trading session on a positive note tracking strong global peers and FII inflows.